How is Stage 4 bladder cancer classified and what are the typical treatment options?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stage 4 Bladder Cancer Classification

Stage 4 bladder cancer is written as either Stage IVA or Stage IVB, depending on the extent of metastatic spread, using the AJCC TNM staging system (8th edition). 1, 2

Stage IVA Classification

Stage IVA bladder cancer includes two distinct presentations 1:

  • T4b, any N, M0: Extravesical tumor invading the pelvic wall and/or abdominal wall, without distant metastases 1
  • Any T, any N, M1a: Any primary tumor with distant metastasis limited to lymph nodes beyond the common iliac nodes 1

These patients are considered to have a "good prognostic risk category within stage IV disease," which expands their treatment options compared to Stage IVB 1.

Stage IVB Classification

Stage IVB is defined as any T, any N, M1b disease—meaning non-lymph node distant metastases to organs such as lung, liver, or bone. 1 This represents the most advanced stage with the poorest prognosis 1.

TNM Component Breakdown

The staging notation uses three components 2, 3:

  • T stage: Depth of tumor invasion into bladder wall and adjacent structures 2
  • N stage: Number and location of metastatic regional lymph nodes 2
  • M stage: Presence and location of distant metastases 2

Clinical Documentation Format

When documenting Stage 4 bladder cancer, specify 2, 3:

  • Clinical staging (cTNM): Based on physical examination, imaging, and cystoscopy 3
  • Pathological staging (pTNM): Based on surgical specimens when available 3
  • Example notation: "cT4b N2 M0" for Stage IVA or "cT3 N1 M1b" for Stage IVB 3

Critical Staging Pitfall

Clinical staging frequently understages patients compared to final pathology—up to 45% of bladders are clinically understaged after TURBT. 2, 4 This occurs primarily because imaging cannot accurately predict true depth of invasion, and size-based criteria miss microscopic metastases in normal-sized lymph nodes 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Staging and Treatment of Bladder Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bladder-Preserving Protocol for Locally Advanced Bladder Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.